Data / Drug companies / Prednisolone acetate
Prednisolone acetate: 10 companies and 17 products in the FDA NDC directory
Prednisolone acetate is listed in the FDA National Drug Code Directory by 10 companies, with 17 products in commercial distribution. 6 of the products (35.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are suspension/ drops, and the newest product started marketing on June 13, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 10
- Products
- 17
- Generic (ANDA) products
- 6 (35.3%)
- Application numbers
- 5
- Routes
- Ophthalmic
- Brand names
- Pred Forte, Pred Mild
- openFDA record search
- api.fda.gov
Companies that list prednisolone acetate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 4 | suspension/ drops | Authorized generics (NDA) | October 11, 2024 |
| Amneal Pharmaceuticals NY LLC | 3 | suspension/ drops | Generic drugs (ANDA) | June 13, 2025 |
| Allergan, Inc. | 2 | suspension/ drops | New drug applications (NDA) | June 1, 1973 |
| Sportpharm LLC | 2 | suspension/ drops | Authorized generics (NDA) | August 19, 1997 |
| Asclemed USA, Inc. | 1 | suspension/ drops | Authorized generics (NDA) | August 19, 1997 |
| Lupin Pharmaceuticals, Inc. | 1 | suspension/ drops | Generic drugs (ANDA) | October 11, 2024 |
| NuCare Pharmaceuticals,Inc. | 1 | suspension/ drops | Authorized generics (NDA) | August 19, 1997 |
| Pacific Pharma, Inc. | 1 | suspension/ drops | Authorized generics (NDA) | August 19, 1997 |
| Redpharm Drug | 1 | suspension/ drops | Generic drugs (ANDA) | October 11, 2024 |
| Sandoz Inc | 1 | suspension/ drops | Authorized generics (NDA) | December 15, 1994 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Suspension/ drops | 17 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Authorized generics (NDA) | 9 | 52.9% |
| Generic drugs (ANDA) | 6 | 35.3% |
| New drug applications (NDA) | 2 | 11.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Corticosteroid | 17 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.